John-Philip Lawo Selected Research

Hizentra

1/2022	Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy.
1/2021	Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.
1/2021	Electrophysiological predictors of response to subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
1/2021	Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study.
1/2020	Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
1/2019	Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
1/2019	Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study.
1/2019	Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
1/2018	Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
1/2016	Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John-Philip Lawo Research Topics

Disease

10	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022 - 01/2016
10	Polyneuropathies (Polyneuropathy) 01/2022 - 01/2016
3	Hereditary Angioedemas 01/2021 - 01/2017
3	Infections 11/2018 - 02/2014
2	Angioedema 07/2021 - 09/2018
2	Primary Immunodeficiency Diseases 02/2014 - 02/2014
1	Hemolysis 01/2020
1	Clinical Deterioration 01/2019
1	Sudden Infant Death (SID) 01/2019
1	Hemophilia A (Haemophilia) 02/2015
1	Asthma (Bronchial Asthma) 09/2007

Drug/Important Bio-Agent (IBA)

12	HizentraIBA 01/2022 - 02/2014
12	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 02/2014
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 01/2016
4	Immunoglobulin G (IgG)IBA 01/2020 - 02/2015
1	Blood Group Antigens (Blood Groups)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2017
1	AntibodiesIBA 02/2015
1	Factor VIII (Coagulation Factor VIII)IBA 02/2015
1	Immunoglobulin IsotypesIBA 02/2015
1	ciclesonide FDA Link 09/2007
1	Fluticasone (Cutivate)FDA LinkGeneric 09/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2018